Dr. Cron Welcomed to SPR Fellows Basic Research Awards Selection Committee
![f3df6a06 3e81 44e7 9aad 9e03c6fc492d](/medicine/peds/images/Announcements/f3df6a06-3e81-44e7-9aad-9e03c6fc492d.jpg)
Learn More About the Department's Fellowships Today!
![29fc66e9 8799 4c1e aa89 36279cb72258](/medicine/peds/images/Announcements/29fc66e9-8799-4c1e-aa89-36279cb72258.png)
Pediatric Residents Impacting Community
Three 2nd year pediatric residents, Bryana Lewis, M.D., Karisa Grizzle, M.D., and Brett LaBrecque, M.D., were featured in the monthly YMCA Community Impact Report. View the report here. Each of the residents share medical presentations with students in local high and middle schools and give advice to aspiring medical professionals.
![ymca](/medicine/peds/images/Announcements/ymca.jpg)
Dr. Kimberlin's 'The Truth About Vaccines' featured in AL.com
![RS13491 David Kimberlin 19RT lpr](/medicine/peds/images/FYI_Fridays/RS13491_David_Kimberlin-19RT-lpr.jpg)
Click here to continue reading the AL.com article by Dr. Kimberlin .
Pediatric Research Office (PRO) Launches Website & Fills Final Positions
The Pediatric Research Office (PRO) is pleased to announce that its final two positions have been filled. Inmaculada (Chichi) Aban, Ph.D., a Professor in the Department of Biostatistics, now has office hours in the PRO (suite 302 of Children’s Harbor Building) three days each week to meet the statistical needs of our researchers, and Eric Macomb will be joining the Office as an informaticist on Sept. 29. Eric was formerly the Director for Clinical Information Technology at Children’s of Alabama. With his move to the PRO, he will be supporting data retrieval for feasibility assessments, preliminary data and research protocols.
Located in Suite 302 of the Children’s Harbor Building, the PRO provides assistance to investigators conducting pediatric research by providing pre-award and post-award support. For more information on the Office, please visit the new Pediatric Research Website. It features information on PRO personnel, as well as information on funding opportunities, research resources including , and training resources boilerplate language for grant applications. For more information, please contact the PRO Administrative Director, Cheryl Perry or Director, David Kimberlin.
Located in Suite 302 of the Children’s Harbor Building, the PRO provides assistance to investigators conducting pediatric research by providing pre-award and post-award support. For more information on the Office, please visit the new Pediatric Research Website. It features information on PRO personnel, as well as information on funding opportunities, research resources including , and training resources boilerplate language for grant applications. For more information, please contact the PRO Administrative Director, Cheryl Perry or Director, David Kimberlin.
ACHIA Releases 2014-2015 Annual Report
![ACHIA.LOGO.CLR](/medicine/peds/images/FYI_Fridays/ACHIA.LOGO.CLR.png)
Click here to view the annual report for the 2014-2015 year.
For more information about ACHIA, visit the website.
Dr. Seifert Receives K23 Mentored Patient-oriented Research Award of $556,286
![Seifert photo 2](/medicine/peds/images/FYI_Fridays/Seifert_photo_2.jpg)
Pediatric Gait & Lab Motion Analysis Lab Opening
![Gait Collage](/medicine/peds/images/FYI_Fridays/Gait_Collage.jpg)
Hyundai 'Hope on Wheels' Grant for Cancer Research
![Hope on Wheels Collage2](/medicine/peds/images/FYI_Fridays/Hope_on_Wheels_Collage2.jpg)
The newly named Hyundai Scholar, Dr. Beierle, will use the funds to develop innovative therapies with the goal of improving outcomes and reducing toxicities in children with neuroblastoma. The event was celebrated at Children's of Alabama with children putting colorful hand prints on the new Hyundai Santa Fe and on the back of Dr. Beierle's coat.
![Dr. Beierle](/medicine/peds/images/FYI_Fridays/Dr._Beierle.jpg)
To view the photo album from Children's photographer, Denise McGill, click here.
To view the AL.com article, click here.
Dr. Ambal Receives NIH Award of $367,500
Dr. Taylor Leading Division of Child Abuse
![Taylor Michael 2 5 13B](/medicine/peds/images/Announcements/Taylor_Michael_2-5-13B.jpg)
Under Taylor’s direction, the new Child Abuse Pediatrics Division will expand the current services provided by the Children’s Hospital Intervention and Prevention Services (CHIPS) Center. The CHIPS Center provides forensic medical evaluations, psychosocial assessments, play therapy, counseling, social work services, prevention education, court support and expert court testimony for victims of child abuse. Taylor hopes to coordinate those services with all local, regional and state resources and organize educational efforts to increase awareness, understanding and reporting of child maltreatment.For a link to the Children's of Alabama press release regarding Dr. Taylor, click here.
Pediatrics Nephology Participation in IROC
The Pediatric Division of Nephrology will be participating in the Improving Renal Outcomes Collaborative Network (IROC). The primary objective of IROC will be to eliminate the survival disparity between children with kidney disease and the general population. Our Pediatric Renal Transplant Program is one of 10 institutions invited to participate in the initial planning and development of the IROC initiative. The initial focus of IROC will be children with a kidney transplant, but in the future we plan to collaborate with the SCOPE dialysis collaborative and relevant research networks to create a Collaborative Chronic Care Network (C3N) that improves care throughout all phases of a patient’s illness including Chronic Kidney Diseases (CKD), dialysis and transplant. Upon successful completion of the design and planning phase and pending sufficient ongoing funding, it is anticipated that IROC will officially launch and start enrolling patients by early 2016. A generous donation from the Porter family has funded the participation and personnel effort that makes our involvement possible. The pediatric kidney transplant program is thrilled to participate in this exciting endeavor that has the potential to transform health outcomes and care for children with kidney disease.
-Dan Feig, M.D., Ph.D., M.S.
Professor of Pediatrics
Director, Division of Nephrology
-Dan Feig, M.D., Ph.D., M.S.
Professor of Pediatrics
Director, Division of Nephrology
CRISPR Correction of Gene Mutation Causing SCID
Read more
Michele Kong, M.D. Among 2015-2016 CCTS Pilot Awardees
![Michele Kong 12RT](/medicine/peds/images/Announcements/Michele_Kong-12RT.jpg)
For more information about the pilot program, please visit the CCTS Research Commons: http://www.uab.edu/ccts/research-commons/pilot-funding
NIH Awards Nearly $34 Million to UAB CCTS
![CCTS Banner 740x5001](/medicine/peds/images/Announcements/CCTS-Banner-740x5001.jpg)
The CCTS will continue to advance its mission to accelerate the delivery of new drugs, methodologies and practices to patients at UAB and throughout a partner network of 11 institutions in the Southeast.
Click here to read more.
Dr. Brad Troxler Grand Rounds Talk
![brad toxler](/medicine/peds/images/nEWS/brad_toxler.jpg)
Click here to view this important and timely information.
Neurophysiology Lab First in World Granted Accreditation
![Nuero](/medicine/peds/images/nEWS/Nuero.jpg)
UABHS Innovation Award Goes To...
![UABHS Innovation Award](/medicine/peds/images/UABHS_Innovation_Award.jpg)
Lauren Nassetta, M.D. accepted the UABHS Innovation Award for the Insulin Safety Team’s Quality project on standardizing subcutaneous insulin at the UABHS Board Meeting on Thursday, Aug. 20. She is pictured with her team.
Clinical Documentation Excellence Department
Q: What is CDE anyway?
A: CDE is a process used by hospitals that employ specialists who review clinical documents for gaps in documentation and provide feedback to physicians. It is a method of obtaining complete, accurate and compliant documentation.
Q: Why can’t you just tell me what to write in my note?
A: Just as an attorney cannot “lead” a witness into a statement, CDE nurses cannot lead physicians in their documentation. A physician may be contacted by a CDE RN during rounds or by a query (communication tool in I-Connect used to clarify documentation) in order to clarify documentation.
Q: So…What’s the point?
A: The primary purpose of accurate, specific and complete health record documentation is continuity of patient care. This serves as a means of communication among healthcare providers. It is also used to evaluate the adequacy and appropriateness of quality care, provide clinical data for research and education and support reimbursement, medical necessity, quality of care measures and public reporting of services rendered by a healthcare entity.
Read more
A: CDE is a process used by hospitals that employ specialists who review clinical documents for gaps in documentation and provide feedback to physicians. It is a method of obtaining complete, accurate and compliant documentation.
Q: Why can’t you just tell me what to write in my note?
A: Just as an attorney cannot “lead” a witness into a statement, CDE nurses cannot lead physicians in their documentation. A physician may be contacted by a CDE RN during rounds or by a query (communication tool in I-Connect used to clarify documentation) in order to clarify documentation.
Q: So…What’s the point?
A: The primary purpose of accurate, specific and complete health record documentation is continuity of patient care. This serves as a means of communication among healthcare providers. It is also used to evaluate the adequacy and appropriateness of quality care, provide clinical data for research and education and support reimbursement, medical necessity, quality of care measures and public reporting of services rendered by a healthcare entity.
Read more
In cancer's aftermath, helping survivors confront "late effects"
![In cancer's aftermath, helping survivors confront "late effects"](/medicine/peds/../../mix/media/k2/items/cache/e2acd849d365015ef08ef5b696dc9e31_L.jpg)
Often, these health problems can be linked back to cancer treatments, including chemotherapy, radiation and even surgeries, Bhatia said. Because these complications can occur “many years after the completion of treatment,” they are called “late effects.” One example involves a particular class of chemotherapy drug known as anthracyclines. “We use these agents often because they are highly effective in a large variety of cancers,” Bhatia said. But research shows that patients who take these drugs have a high risk of developing congestive heart failure many years later.
Read more